Volume 18, Issue 6, Pages (September 2015)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States Shital Kamble, PhD, Kevin A. Schulman, MD, Shelby.
Volume 14, Issue 8, Pages (December 2011)
Change in β2-agonist use after severe life events in adults with asthma: A population- based cohort study  Raija Lietzén, Pekka Virtanen, Mika Kivimäki,
Lack of Association Between Extracranial Carotid and Vertebral Artery Disease and Stroke After Transcatheter Aortic Valve Replacement  Chetan P. Huded,
Increased Risk of Lost Workdays Prior to the Diagnosis of Sleep Apnea
Volume 18, Issue 2, Pages (March 2015)
Persistence with statin therapy in diabetic and non-diabetic persons: a nation-wide register study in in Finland  Arja Helin-Salmivaara, Piia.
Volume 18, Issue 4, Pages (June 2015)
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 15, Issue 6, Pages (September 2012)
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
Volume 81, Issue 5, Pages (March 2012)
Examining the Value of Menopausal Symptom Relief Among US Women
Aspirin Use Among U.S. Adults
Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 
Volume 17, Issue 2, Pages (March 2014)
Volume 19, Issue 6, Pages (September 2016)
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?  Sripal Bangalore, MD,
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Effect of Statin Adherence on Cerebrovascular Disease in Primary Prevention  Sylvie Perreault, BPharm, PhD, Laura Ellia, MSc, Alice Dragomir, MSc, Robert.
The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.
Sayed H. Naderi, BMedSci, Jonathan P. Bestwick, MSc, David S. Wald, MD 
Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study  Prof Marko.
Predictors of first-year statin medication discontinuation: A cohort study  Heli Halava, MD, Risto Huupponen, MD, PhD, Jaana Pentti, BSc, Mika Kivimäki,
Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease  Nina Raju, MD, MsC, Magdalena Sobieraj-Teague, MBBS, Jack Hirsh, MD,
Dysfunctional Uterine Activity in Labour and Premature Adverse Cardiac Events: Population-Based Cohort Study  Alyssa Kahane, BSc, Alison L. Park, MSc,
Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study  Simon Sawhney, MBChB, Angharad.
Impact of Statins on Physical Activity and Fitness: Ally or Adversary?
Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population- Based Cohort Study  Walter A. Rocca, MD, MPH, Liliana Gazzuola-Rocca,
Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life  Janne J. Jokinen, MD, Anu K. Turpeinen,
Emma J. Aarnio, MSc (Pharm), Janne A
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization 
Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment  Dr Vittal Mogasale,
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W.
Nimarta Singh, BA, Kiang Liu, PhD, Lu Tian, ScD, Michael H
Volume 18, Issue 12, Pages (December 2017)
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Cost-Effectiveness Analysis of Atorvastatin versus Rosuvastatin in Primary and Secondary Cardiovascular Prevention Populations in Brazil and Columbia 
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Combined effects of smoking and peripheral arterial disease on all-cause and cardiovascular disease mortality in a Chinese male cohort  Yingyi Luo, MD,
Volume 97, Issue 1, Pages (January 1990)
Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease  Matthew E. Oster, MD, Matthew J.
Gabriel Loor, MD, Liang Li, PhD, Joseph F
Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand  Panrasri Khonputsa,
Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)
Volume 81, Issue 5, Pages (March 2012)
Sophie K. Kieffer, Nina Zisko, PhD, Jeff S
Lifestyle factors and risk of sickness absence from work: a multicohort study  Prof Marianna Virtanen, PhD, Jenni Ervasti, PhD, Prof Jenny Head, MSc, Tuula.
David A. Barzilai, Mendel E. Singer 
Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV  Kevin C Abbott, MD,
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial  Michael S. Conte,
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Improved prognosis of diabetic nephropathy in type 1 diabetes
Observations on emerging patterns of asthma in our society
Volume 70, Issue 7, Pages (October 2006)
The Impact of Statins on Abdominal Aortic Aneurysm Growth, Rupture, and Perioperative Outcomes: A Systematic Review and Meta-Analysis  Konrad Salata,
The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study  Tetyana.
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization 
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites  Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States  Ahmet Ergin, MD, PhD, MPH, Paul.
Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients  Peter P. Toth, MD, PhD, Sephy Philip,
Presentation transcript:

Volume 18, Issue 6, Pages 896-905 (September 2015) Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland  Piia K. Rannanheimo, MSc(Pharm), Pekka Tiittanen, MSc, Juha Hartikainen, MD, Arja Helin-Salmivaara, MD, PhD, Risto Huupponen, MD, Jussi Vahtera, MD, Maarit Jaana Korhonen, LicSc(Pharm), PhD  Value in Health  Volume 18, Issue 6, Pages 896-905 (September 2015) DOI: 10.1016/j.jval.2015.06.002 Copyright © 2015 Terms and Conditions

Fig. 1 Flowchart of the cohort definition. CV, cardiovascular. Value in Health 2015 18, 896-905DOI: (10.1016/j.jval.2015.06.002) Copyright © 2015 Terms and Conditions

Fig. 2 Study design. In the analyses exposure was estimated using three alternative approaches: In the unadjusted and multivariable adjusted models as baseline adherence from the index date to the end of first year of follow up (t0–t1); in the inverse probability weighted analyses as a time varying adherence from the index date until the end of pre-event (CVD-event or death) year or the end of follow-up (t0–t1 or t0–t2 or t0–t3) which ever occurred first; and in the sensitivity analyses from the year preceding the event or end of follow-up (t0–t1 or t1–t2 or t2–t3). PDC, proportion of days covered. (Color version of figure is available online.) Value in Health 2015 18, 896-905DOI: (10.1016/j.jval.2015.06.002) Copyright © 2015 Terms and Conditions